CL2011001453A1 - Metodo para identificar un anticuerpo o fragmento del mismo de union a antigeno expresado en una celula, particulamente una celula b, que se une especificamente a un antigeno de interes de la superficie celular. - Google Patents
Metodo para identificar un anticuerpo o fragmento del mismo de union a antigeno expresado en una celula, particulamente una celula b, que se une especificamente a un antigeno de interes de la superficie celular.Info
- Publication number
- CL2011001453A1 CL2011001453A1 CL2011001453A CL2011001453A CL2011001453A1 CL 2011001453 A1 CL2011001453 A1 CL 2011001453A1 CL 2011001453 A CL2011001453 A CL 2011001453A CL 2011001453 A CL2011001453 A CL 2011001453A CL 2011001453 A1 CL2011001453 A1 CL 2011001453A1
- Authority
- CL
- Chile
- Prior art keywords
- antigen
- cell
- antibody
- cells
- interest
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/241—Tumor Necrosis Factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
- G01N33/5052—Cells of the immune system involving B-cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
- G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15504109P | 2009-02-24 | 2009-02-24 | |
US15510509P | 2009-02-24 | 2009-02-24 | |
CH8322009 | 2009-06-02 | ||
PCT/CH2009/000219 WO2009155723A2 (en) | 2008-06-25 | 2009-06-25 | STABLE AND SOLUBLE ANTIBODIES INHIBITING TNFα |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2011001453A1 true CL2011001453A1 (es) | 2012-02-24 |
Family
ID=48917567
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2011001453A CL2011001453A1 (es) | 2009-02-24 | 2011-06-15 | Metodo para identificar un anticuerpo o fragmento del mismo de union a antigeno expresado en una celula, particulamente una celula b, que se une especificamente a un antigeno de interes de la superficie celular. |
Country Status (12)
Country | Link |
---|---|
JP (3) | JP6161655B2 (ja) |
KR (4) | KR102059866B1 (ja) |
CN (1) | CN105116138A (ja) |
BR (1) | BRPI1005398A2 (ja) |
CL (1) | CL2011001453A1 (ja) |
ES (1) | ES2618181T3 (ja) |
IL (4) | IL226956A (ja) |
MX (1) | MX352922B (ja) |
PH (1) | PH12014502468A1 (ja) |
RU (2) | RU2577965C2 (ja) |
SG (3) | SG10201708233VA (ja) |
ZA (1) | ZA201103125B (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110016462B (zh) * | 2019-02-20 | 2020-04-24 | 优睿赛思(武汉)生物科技有限公司 | 从脾脏细胞中高效分离单个抗原特异性b淋巴细胞的方法 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63253098A (ja) * | 1987-04-10 | 1988-10-20 | Ube Ind Ltd | ヒト抗体に対するモノクロ−ナル抗体、その製法及び用途 |
IL91948A (en) * | 1988-10-26 | 1994-05-30 | Immunomedics | Removal of immunoreactive components from a sample |
US5417972A (en) * | 1993-08-02 | 1995-05-23 | The Board Of Trustees Of The Leland Stanford Junior University | Method of killing B-cells in a complement independent and an ADCC independent manner using antibodies which specifically bind CDIM |
KR0119909B1 (ko) * | 1993-10-05 | 1997-10-20 | 김은영 | 플로우 사이토미터를 이용한 고상형 면역 측정방법 |
KR20050085971A (ko) * | 1995-04-27 | 2005-08-29 | 아브게닉스, 인크. | 면역화된 제노마우스 유래의 인간 항체 |
WO1998002462A1 (en) * | 1996-07-16 | 1998-01-22 | Morphosys Gesellschaft Für Proteinoptimierung Mbh | Immunoglobulin superfamily domains and fragments with increased solubility |
WO2003097697A2 (en) * | 2002-05-22 | 2003-11-27 | Esbatech Ag | Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same |
CN1396182A (zh) * | 2002-07-31 | 2003-02-12 | 陕西超英生物医学研究开发有限公司 | 人内皮生长因子受体2蛋白全人单克隆抗体及其制备方法 |
WO2004016740A2 (en) * | 2002-08-15 | 2004-02-26 | Epitomics, Inc. | Humanized rabbit antibodies |
CA2505924A1 (en) * | 2002-11-13 | 2004-05-27 | Micromet Ag | Method for identifying antigen specific b cells |
JP4336812B2 (ja) * | 2003-03-07 | 2009-09-30 | 博夫 岩田 | 細胞に発現する表面抗原を迅速に同定するための分析方法 |
EP1623229A2 (en) * | 2003-05-15 | 2006-02-08 | Cytos Biotechnology AG | Selection of b cells with specificity of interest: method of preparation and use |
EP1651659A4 (en) * | 2003-08-07 | 2008-09-17 | Epitomics Inc | METHOD FOR HUMANIZATION OF MONOCLONAL RABBIT ANTIBODIES |
CA2655511C (en) * | 2005-07-01 | 2017-03-21 | John Schrader | Methods of isolating cells and generating monoclonal antibodies |
US20070134249A1 (en) | 2005-12-08 | 2007-06-14 | Genitope Corporation | Combination therapy and antibody panels |
RU2008130898A (ru) * | 2005-12-28 | 2010-02-10 | Асубио Фарма Ко., Лтд. (Jp) | Антитело против периостина и содержащая его фармацевтическая композиция для профилактики или лечения заболевания, в развитии которого участвует периостин |
CN102585002A (zh) * | 2006-06-02 | 2012-07-18 | 瑞泽恩制药公司 | 人il-6受体的高亲和力抗体 |
WO2008004834A1 (en) * | 2006-07-06 | 2008-01-10 | Isu Abxis Co., Ltd | Humanized monoclonal antibody highly binding to epidermal growth factor receptor, egf receptor |
-
2010
- 2010-02-22 SG SG10201708233VA patent/SG10201708233VA/en unknown
- 2010-02-22 SG SG2014014864A patent/SG2014014864A/en unknown
- 2010-02-22 ES ES10705086.6T patent/ES2618181T3/es active Active
- 2010-02-22 MX MX2015017453A patent/MX352922B/es unknown
- 2010-02-22 SG SG10201408247SA patent/SG10201408247SA/en unknown
- 2010-02-22 CN CN201510261116.5A patent/CN105116138A/zh active Pending
- 2010-02-22 KR KR1020197005221A patent/KR102059866B1/ko active IP Right Grant
- 2010-02-22 RU RU2011124039/10A patent/RU2577965C2/ru active
- 2010-02-22 BR BRPI1005398-0A patent/BRPI1005398A2/pt not_active Application Discontinuation
- 2010-02-22 KR KR1020167035683A patent/KR101817279B1/ko active IP Right Grant
- 2010-02-22 KR KR1020167003693A patent/KR101689791B1/ko active IP Right Grant
- 2010-02-22 KR KR1020187000320A patent/KR20180005752A/ko active Application Filing
-
2011
- 2011-04-28 ZA ZA2011/03125A patent/ZA201103125B/en unknown
- 2011-06-15 CL CL2011001453A patent/CL2011001453A1/es unknown
-
2013
- 2013-06-13 IL IL226956A patent/IL226956A/en active IP Right Grant
- 2013-06-13 IL IL226955A patent/IL226955A/en active IP Right Grant
-
2014
- 2014-11-05 PH PH12014502468A patent/PH12014502468A1/en unknown
-
2015
- 2015-03-26 IL IL237985A patent/IL237985B/en active IP Right Grant
- 2015-05-19 JP JP2015101581A patent/JP6161655B2/ja active Active
-
2017
- 2017-04-28 JP JP2017090650A patent/JP6604989B2/ja not_active Expired - Fee Related
- 2017-10-09 RU RU2017135831A patent/RU2017135831A/ru not_active Application Discontinuation
-
2018
- 2018-09-14 JP JP2018172287A patent/JP2018196395A/ja active Pending
- 2018-11-20 IL IL26315818A patent/IL263158B/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
ZA201103125B (en) | 2012-08-29 |
RU2017135831A3 (ja) | 2019-04-09 |
KR20180005752A (ko) | 2018-01-16 |
IL226955A0 (en) | 2013-07-31 |
SG10201408247SA (en) | 2015-02-27 |
PH12014502468B1 (en) | 2016-01-18 |
KR102059866B1 (ko) | 2019-12-27 |
KR101817279B1 (ko) | 2018-01-10 |
SG10201708233VA (en) | 2017-11-29 |
JP2015146825A (ja) | 2015-08-20 |
RU2577965C2 (ru) | 2016-03-20 |
SG2014014864A (en) | 2014-09-26 |
MX352922B (es) | 2017-12-14 |
KR20160150642A (ko) | 2016-12-30 |
RU2011124039A (ru) | 2012-12-20 |
IL263158A (en) | 2018-12-31 |
JP2017192384A (ja) | 2017-10-26 |
JP2018196395A (ja) | 2018-12-13 |
KR101689791B1 (ko) | 2016-12-26 |
JP6604989B2 (ja) | 2019-11-13 |
KR20160022397A (ko) | 2016-02-29 |
PH12014502468A1 (en) | 2016-01-18 |
JP6161655B2 (ja) | 2017-07-12 |
CN105116138A (zh) | 2015-12-02 |
IL263158B (en) | 2019-10-31 |
RU2017135831A (ru) | 2019-04-09 |
ES2618181T3 (es) | 2017-06-21 |
IL226956A (en) | 2015-04-30 |
IL226955A (en) | 2015-04-30 |
KR20190020202A (ko) | 2019-02-27 |
BRPI1005398A2 (pt) | 2019-03-26 |
IL226956A0 (en) | 2013-07-31 |
IL237985B (en) | 2018-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2012003375A1 (es) | Anticuerpo monoclonal que se une a enzima ariloxialcanoato dioxigenasa (aad-12); linea celular de hibridomas que produce dicho anticuerpo; metodos para detectar la presencia de la enzima aad-12; metodo para la deteccion cuantitativa de una enzima aad-12. | |
AR118118A2 (es) | Anticuerpos bivalentes biespecíficos | |
CO2017006651A2 (es) | Anticuerpos anti-c5 | |
CL2008002085A1 (es) | Anticuerpo humanizado anti-cd79b/igbeta/b29; polinucleotido codificacnte, vector, celula huesped; metodo de fabricacion; inmunoconjugado; composicion farmaceutica; uso para tratar cancer; metodo in vitro para determinar presencia de cd79b, oinhibir crecimiento de celulas quqe expresa cd79b; ensayo in vitro para detectar celulas b | |
CR20150437A (es) | Construcciones de anticuerpos para cdh19 y cd3 | |
EP3495799A3 (en) | A method for measurement of a component in cells | |
CL2008001175A1 (es) | Metodo para distinguir semillas que contienen un elemento genetico de interes a partir de una muestra de un lote,basado en la presencia de una proteina marcadora fluorescente roja. | |
AR101844A1 (es) | Anticuerpos y conjugados modificados genéticamente con cisteína | |
UY32501A (es) | Anticuerpo antagonista específico para el heterodímero alfa4-beta7 | |
CL2012000254A1 (es) | Anticuerpo aislado de unión a antígeno que se une a proteína atenuante de linfocitos b y t (btla); ácido nucleico que lo codifica; composición que comprende a dicho anticuerpo; y vector de expresión. | |
AR093984A1 (es) | Anticuerpos que se unen a ligando 1 de muerte programada (pd-l1) humano | |
AR091116A1 (es) | Anticuerpos biespecificos y sus metodos de uso | |
MX2017015011A (es) | Ensayo a base de celulas para detectar homodimeros anti-cd3. | |
CL2011002039A1 (es) | Anticuerpo humanizado que se une al cd19 humano; acido nucleico aislado que codifica dicho anticuerpo; vector y celula huesped; composicion e inmunoconjugado; metodo para inhibir el crecimiento de celulas de tumor que expresan cd19. | |
CR20120371A (es) | Antagonistas de pcsk9 | |
TR201901668T4 (tr) | Sınırlı bir immünoglobulin hafif zincir repertuvarını eksprese eden fareler. | |
EP4249605A3 (en) | Methods for analyte detection | |
PE20190229A1 (es) | Anticuerpos anti-fcrn | |
BR112014025384A8 (pt) | método e sistema para executar ensaio automatizado e métodos para executar teste reflexivo em vários exemplares | |
CL2012000822A1 (es) | Acido nucleico aislado del virus de peces prv; polipeptido aislado; anticuerpo que se une a dicho polipeptido; metodo para determinar la presencia o ausencia de prv en una muestra biologica; arn interferente; metodo para reducir nivel de proteina viral. | |
CL2011002611A1 (es) | Anticuerpo aislado anti-cadherina-17; molecula de acido nucleico que lo codifica; vector; celula huesped; metodo de produccion; inmunoconjugado que lo comprende; composicion que lo comprende; y su uso para tratar o prevenir una enfermedad asociada con celulas objetivo que expresan cadherina-17. | |
BR112016002685A2 (pt) | ensaios para timp2 que apresentam melhor desempenho em amostras biológicas | |
CY1115624T1 (el) | Μεθοδος ανιχνευσης σε καποιο βιολογικο δειγμα των ειδικων αντισωματων για τα αβ | |
CL2011002973A1 (es) | Metodo para detectar anticuerpos en una muestra que comprende contactar una muestra con un soporte que tiene fijado un peptoide; kit para detectar anticuerpos que son indicativos de una enfermedad neurodegenerativa. | |
BR112013011167A2 (pt) | "exame de suplementos eficientes e efetivos para o desenvolvimento de meio quimicamente definido em cultura de células." |